Ando Y, Suhr O, Yamashita T, Ohlsson P I, Holmgren G, Obayashi K, Terazaki H, Mambule C, Uchino M, Ando M
Department of Medicine, University of Umeå, Sweden.
Neurosci Lett. 1997 Dec 5;238(3):123-6. doi: 10.1016/s0304-3940(97)00868-9.
To detect the variant transthyretin (TTR; Met30) in cerebrospinal fluid (CSF) of familial amyloidotic polyneuropathy (FAP) patients, we have applied a new method using a centrifugal concentrator device and electrospray ionization mass spectrometry (ESI-MS). Only 100 microl of CSF and 30 microl of the antibody for TTR was needed for the analysis. After preparation of the samples with anti-TTR antibody, they were passed through a 1000 kDa cut-off centrifugal concentrator which retained the antibody. By analyzing the obtained filtrate with ESI-MS, three predominant forms of normal and their variant forms of TTR were detected in CSF samples. TTR (Met30), with a molecular weight 32.0 Da higher than the normal form of TTR, was found in all FAP patients' materials. Although the ratio of the three major peaks of TTR were different in each individual, they were always found in CSF and sera. This method will contribute to make a diagnosis of neurologic disorders having a mutant protein in CSF as well as serum.
为了检测家族性淀粉样多神经病(FAP)患者脑脊液(CSF)中的变异型转甲状腺素蛋白(TTR;Met30),我们应用了一种使用离心浓缩器装置和电喷雾电离质谱(ESI-MS)的新方法。分析仅需要100微升脑脊液和30微升TTR抗体。在用抗TTR抗体制备样品后,将它们通过截留分子量为1000 kDa的离心浓缩器,该浓缩器保留抗体。通过用ESI-MS分析获得的滤液,在脑脊液样品中检测到三种主要形式的正常TTR及其变异形式。在所有FAP患者的样本中均发现了分子量比正常TTR高32.0 Da的TTR(Met30)。尽管每个个体中TTR三个主峰的比例不同,但它们始终存在于脑脊液和血清中。该方法将有助于诊断脑脊液以及血清中存在突变蛋白的神经系统疾病。